Skip to main content

Table 1 Demographic and perioperative data

From: Efficacy and safety of different bupivacaine concentrations in periarticular infiltration combined with adductor canal block for bilateral total knee arthroplasty: a randomized controlled trial

Variables

Group A (n = 28)

(300 mg bupivacaine)

Group B (n = 29)

(200 mg bupivacaine)

P

Age (years)

67.9 (8.5)

67.7 (7.6)

0.925

Female sex

26 (92.9%)

28 (96.6%)

0.611

BMI (kg/m2)

27.7 (4.4)

26.8 (4.7)

0.480

Diabetes

6 (21.4%)

4 (13.8%)

0.449

Preoperative Hct (%)

37.5 (3.1)

38.6 (3.0)

0.172

CrCl (mL/min)

85.0 (13.7)

84.7 (14.7)

0.943

Operation time (min)

135.9 (34.1)

120.2 (22.4)

0.061

Morphine consumption (mg)

   

 0–24 h

6 (3.0–9.8)

6 (3.5–10.5)

0.779

 24–48 h

3 (0–8.8)

4 (1.0–6.0)

0.776

Postoperative nausea vomiting

10 (35.7%)

13 (44.8%)

0.483

Walk within 2 days post-TKA

20 (71.4%)

27 (93.1%)

0.041

Length of stay (days)

6.3 (1.2)

6.7 (2.5)

0.405

  1. Data are presented as mean (standard deviation), median (interquartile range), or number (%)
  2. BMI body mass index, Hct hematocrit, CrCl creatinine clearance, TKA total knee arthroplasty